SAS Names Gavin Day as Chief Operating Officer
"As our technology, business, and the way we engage with customers have evolved, and as SAS prepares to operate as a public company, Gavin's move into the COO role provides greater alignment of revenue-generating business functions and the ability to serve our customers better," said SAS CEO
Prior to this appointment, Day served as Executive Vice President and head of a global division focused on core operations and public company readiness. Charged with being a change agent, Day has guided the transformation of numerous internal systems and processes to better prepare SAS to operate as a public company, and continues to strengthen relationships with technology partners and channel partners around the world.
"I'm honored to step into the COO role and grateful to
Day's 25-year career at SAS spans both R&D and sales. He previously served as SAS' Senior Vice President of Technology, overseeing technology development within the R&D division to define and communicate SAS' technology vision. He also held the role of Senior Vice President of US Commercial Sales, managing several business, presales, and sales operations teams. Before joining SAS, Day worked in various leadership roles at DataFlux, an industry-leading provider of data management software, which SAS acquired.
About SAS
SAS is a global leader in data and AI. With SAS software and industry-specific solutions, organizations transform data into trusted decisions. SAS gives you THE POWER TO KNOW®.
SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the
Editorial Contacts:
[email protected]
919-531-2676
sas.com/news
View original content to download multimedia:https://www.prnewswire.com/news-releases/sas-names-gavin-day-as-chief-operating-officer-302444430.html
SOURCE SAS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Allison Transmission Holdings Set to Join S&P MidCap 400 and Goodyear Tire & Rubber to Join S&P SmallCap 600
- Helix BioPharma Corp. Strengthens Executive Leadership to Support U.S. Listing Strategy and Next Phase of Clinical Development
- Teck Announces the Mailing of a Letter of Transmittal in Connection with the Merger of Equals with Anglo American
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share